Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

US Coronary Angiography Devices Market

ID: MRFR/HC/54969-HCR
128 Pages
Rahul Gotadki
Last Updated: April 06, 2026

US Coronary Angiography Devices Market Research Report By Product Type (Angiography Catheters, Contrast Media, Angiography Systems, Inflatable Balloons, Guidewires), By Application (Coronary Angiography, Peripheral Angiography, Neuro Angiography, Interventional Angiography), By End-user (Hospitals, Ambulatory Surgical Centers, Diagnostic Imaging Centers, Specialty Clinics), and By Technology (Digital Angiography, Computed Tomography Angiography, Magnetic Resonance Angiography) - Growth & Industry Forecast 2025 To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

US Coronary Angiography Devices Market Infographic
Purchase Options

US Coronary Angiography Devices Market Summary

As per Market Research Future analysis, the US coronary angiography devices market size was estimated at 2871.64 USD Million in 2024. The US coronary angiography-devices market is projected to grow from 3199.59 USD Million in 2025 to 9436.18 USD Million by 2035, exhibiting a compound annual growth rate (CAGR) of 11.4% during the forecast period 2025 - 2035

Key Market Trends & Highlights

The US coronary angiography-devices market is poised for growth driven by technological advancements and increasing demand for minimally invasive procedures.

  • Technological advancements are enhancing the efficacy and precision of coronary angiography devices.
  • The demand for minimally invasive procedures is rising, reflecting a shift in patient preferences towards less invasive treatment options.
  • The largest segment in the market is the diagnostic angiography devices, while the fastest-growing segment is the interventional angiography devices.
  • Key market drivers include the rising incidence of cardiovascular diseases and increased healthcare expenditure.

Market Size & Forecast

2024 Market Size 2871.64 (USD Million)
2035 Market Size 9436.18 (USD Million)
CAGR (2025 - 2035) 11.42%

Major Players

Abbott (US), Boston Scientific (US), Medtronic (US), Siemens Healthineers (DE), Philips (NL), GE Healthcare (US), Cardinal Health (US), Terumo (JP), B. Braun (DE)

Our Impact
Enabled $4.3B Revenue Impact for Fortune 500 and Leading Multinationals
Partnering with 2000+ Global Organizations Each Year
30K+ Citations by Top-Tier Firms in the Industry

US Coronary Angiography Devices Market Trends

The coronary angiography devices market is currently experiencing notable advancements. These advancements are driven by technological innovations and an increasing prevalence of cardiovascular diseases. The integration of advanced imaging techniques and minimally invasive procedures is reshaping the landscape of this market. Enhanced precision in diagnostics and treatment options is likely to improve patient outcomes significantly. Furthermore, the growing awareness of heart health among the population appears to be contributing to a higher demand for these devices. As healthcare providers focus on improving efficiency and reducing recovery times, the adoption of cutting-edge technologies is expected to rise. In addition, regulatory support and funding initiatives from government bodies are fostering growth within the coronary angiography-devices market. These efforts aim to enhance healthcare infrastructure and ensure that patients have access to the latest medical technologies. The collaboration between manufacturers and healthcare institutions is also likely to facilitate the development of innovative solutions tailored to meet the specific needs of patients. Overall, the market seems poised for continued expansion as it adapts to the evolving healthcare landscape and addresses the challenges posed by cardiovascular diseases.

Technological Advancements

The coronary angiography-devices market is witnessing rapid technological advancements, particularly in imaging techniques and device design. Innovations such as three-dimensional imaging and real-time visualization are enhancing diagnostic accuracy. These developments are likely to improve procedural outcomes and patient safety.

Increased Demand for Minimally Invasive Procedures

There is a growing trend towards minimally invasive procedures within the coronary angiography-devices market. Patients and healthcare providers are increasingly favoring techniques that reduce recovery times and minimize complications. This shift is expected to drive the adoption of advanced angiography devices.

Regulatory Support and Funding Initiatives

Government support through regulatory frameworks and funding initiatives is playing a crucial role in the growth of the coronary angiography-devices market. These measures aim to enhance access to innovative technologies, ensuring that healthcare providers can offer the latest treatment options to patients.

US Coronary Angiography Devices Market Drivers

Growing Geriatric Population

The aging population in the US is a significant factor propelling the coronary angiography-devices market. As individuals age, the risk of developing cardiovascular diseases escalates, necessitating regular monitoring and intervention. The US Census Bureau projects that by 2030, all baby boomers will be over 65 years old, leading to a substantial increase in the demand for cardiovascular care. This demographic shift is likely to result in heightened utilization of coronary angiography devices, as healthcare providers seek to manage the health of older patients effectively. Consequently, the market is expected to expand as hospitals and clinics adapt to the needs of this growing population segment.

Increased Healthcare Expenditure

Rising healthcare expenditure in the US is another critical driver for the coronary angiography-devices market. According to the Centers for Medicare & Medicaid Services, national health spending is projected to reach $6.2 trillion by 2028, reflecting a growth rate of approximately 5.4% annually. This increase in spending facilitates the adoption of advanced medical technologies, including coronary angiography devices. As healthcare systems allocate more resources towards innovative diagnostic tools, the market is likely to experience robust growth. Enhanced funding for cardiovascular care initiatives further supports the expansion of this market, as healthcare providers invest in the latest angiography technologies to improve patient outcomes.

Rising Incidence of Cardiovascular Diseases

The increasing prevalence of cardiovascular diseases in the US is a primary driver for the coronary angiography-devices market. According to the American Heart Association, cardiovascular diseases account for approximately 697,000 deaths annually, representing about 1 in every 5 deaths. This alarming statistic underscores the urgent need for effective diagnostic tools, such as coronary angiography devices, to facilitate early detection and treatment. As healthcare providers strive to address this growing health crisis, investments in advanced angiography technologies are likely to surge. The market is projected to expand as hospitals and clinics adopt these devices. This adoption aims to improve patient outcomes and reduce mortality rates associated with heart diseases.

Rising Awareness and Education on Heart Health

The growing awareness and education regarding heart health among the US population are driving the coronary angiography-devices market. Public health campaigns and initiatives by organizations such as the American Heart Association have significantly increased knowledge about the importance of early detection and treatment of cardiovascular diseases. This heightened awareness encourages individuals to seek medical advice and undergo diagnostic procedures, including coronary angiography. As more patients become proactive about their heart health, the demand for angiography devices is expected to rise. This trend may lead to increased investments in the development and distribution of advanced coronary angiography technologies, further propelling market growth.

Technological Innovations in Imaging Techniques

Technological advancements in imaging techniques are significantly influencing the coronary angiography-devices market. Innovations such as 3D imaging, optical coherence tomography, and advanced fluoroscopy systems enhance the precision and effectiveness of coronary angiography procedures. These technologies allow for better visualization of coronary arteries, leading to improved diagnostic accuracy and treatment planning. The integration of artificial intelligence in image analysis further streamlines workflows and reduces procedural times. As a result, healthcare facilities are increasingly investing in state-of-the-art angiography devices, which is expected to drive market growth. The market is anticipated to witness a compound annual growth rate (CAGR) of around 6% over the next few years.

Market Segment Insights

By Type: Angiography Systems (Largest) vs. Angiography Catheters (Fastest-Growing)

The market share distribution within the US coronary angiography-devices market reveals that Angiography Systems hold the largest share, underscoring their essential role in diagnostic procedures. Angiography Catheters and Contrast Media are also significant but take a secondary position in terms of overall revenue contribution. This distribution indicates a mature market where some segments are well-established, while others are rapidly gaining prominence among healthcare providers. Growth trends in the segment indicate a robust expansion, driven by advancements in technology and increasing demand for minimally invasive procedures. Angiography Catheters are witnessing the fastest growth, attributed to rising prevalence of cardiovascular diseases and the subsequent need for efficient diagnostic tools. The increasing adoption of innovative systems and materials is expected to bolster this segment's growth, making it an attractive focus for manufacturers.

Angiography Systems (Dominant) vs. Angiography Catheters (Emerging)

Angiography Systems are characterized by their comprehensive capabilities in performing diagnostic and therapeutic procedures, making them a dominant force in the segment. Their integration with advanced imaging techniques enhances accuracy and efficiency, leading to increased utilization in clinical practice. On the other hand, Angiography Catheters represent an emerging segment, known for their critical function in facilitating blood flow and delivering treatments. The fast-paced innovation in catheter design, including improvements in flexibility and guiding capabilities, allows for enhanced performance in complex cases, driving their rapid adoption in the healthcare sector.

By Application: Coronary Angiography (Largest) vs. Interventional Angiography (Fastest-Growing)

The market share distribution in the application segment of the US coronary angiography-devices market reveals that coronary angiography significantly leads, driven by its essential role in diagnosing heart diseases. Peripheral angiography and neuro angiography also hold notable portions of the market, but they lag behind coronary angiography in terms of share. Interventional angiography is witnessing an increasing share as a result of advancements in technology and improved procedures, which cater to a growing demand for minimally invasive solutions. In terms of growth trends, interventional angiography is emerging as a segment to watch due to its innovative approaches and enhanced patient outcomes. Factors propelling this growth include an aging population, increasing prevalence of cardiovascular diseases, and ongoing research leading to new device development. Additionally, industry collaboration and investments in healthcare infrastructure support the advancement of interventional angiography technologies, positioning it as a vital component of the overall market growth.

Coronary Angiography (Dominant) vs. Interventional Angiography (Emerging)

The coronary angiography segment is established as the dominant force in the US coronary angiography-devices market, largely due to its crucial role in the detection and management of coronary artery diseases. This application utilizes specialized catheters and contrast agents to visualize coronary arteries, making it indispensable in clinical practices. On the other hand, interventional angiography is rapidly emerging, characterized by cutting-edge techniques that allow for the treatment of vascular disorders with less invasive interventions. This segment is driven by technological advancements, significant research investments, and a shift towards outpatient procedures. Together, these segments embody the extensive capabilities of angiography devices, catering to diverse patient needs while shaping the future of cardiovascular care.

By End User: Hospitals (Largest) vs. Ambulatory Surgical Centers (Fastest-Growing)

In the US coronary angiography-devices market, hospitals dominate the end-user segment, capturing the largest share due to their comprehensive cardiac care services and advanced technological capabilities. Ambulatory surgical centers, while smaller in market share, are gaining traction due to their flexible scheduling and cost-effective procedures. The growth trends in this segment are driven by an increasing prevalence of cardiovascular diseases and the need for efficient healthcare delivery. Specialty clinics are also emerging as vital players by offering targeted treatments for specific conditions. The combination of technological advancements in angiography devices and the shift towards outpatient services further supports the growth of ambulatory surgical centers, positioning them as a key focus for future investments.

Hospitals (Dominant) vs. Ambulatory Surgical Centers (Emerging)

Hospitals represent the dominant segment in the end-user classification, attributed to their expansive resources and capability to provide intricate diagnostic procedures and emergency care. They are equipped with advanced angiography devices that support a range of cardiovascular interventions, contributing to their market strength. Conversely, ambulatory surgical centers are emerging as vital alternatives, attracting patients with their lower costs and shorter wait times for procedures. These centers typically focus on outpatient services, which are becoming increasingly preferred due to regulatory changes and patient preferences for minimally invasive solutions. Their agility in adopting new technologies positions them strongly within the market, allowing them to grow rapidly as they fulfill a critical role in healthcare delivery.

By Technology: Digital Angiography (Largest) vs. Computed Tomography Angiography (Fastest-Growing)

In the US coronary angiography-devices market, Digital Angiography holds a significant share, being the most widely used technology for imaging procedures. This method boasts advanced imaging capabilities, enabling accurate visualization of vascular structures, which has led to its dominant position among clinicians and healthcare providers. Following closely, Computed Tomography Angiography has begun to capture greater attention due to its rapid imaging capabilities and improved patient outcomes, establishing itself as a formidable competitor in the market. Growth trends indicate that while Digital Angiography remains the frontrunner, Computed Tomography Angiography is gaining momentum as technology advances and the demand for efficient diagnostic solutions increases. Factors driving this growth include an aging population with rising cardiovascular diseases, increased adoption of minimally invasive procedures, and continuous innovations in imaging technologies. Magnetic Resonance Angiography, while less prevalent, is also seeing gradual acceptance among niche segments due to its non-invasive nature and ability to provide detailed imagery without ionizing radiation.

Technology: Digital Angiography (Dominant) vs. Computed Tomography Angiography (Emerging)

Digital Angiography is characterized by its high-resolution images and real-time feedback, making it preferred for complex interventions and diagnostic evaluations. Its established market presence stems from its long-standing reliability and efficacy in diagnosing cardiovascular conditions. Conversely, Computed Tomography Angiography is an emerging technology that leverages advanced imaging algorithms and rapid acquisition techniques, which appeal to healthcare settings requiring quick decision-making. This technology is increasingly being utilized for its ability to present comprehensive results in a short timeframe, positioning it favorably for growth in the current market dynamics.

Get more detailed insights about US Coronary Angiography Devices Market

Key Players and Competitive Insights

The coronary angiography-devices market is characterized by a dynamic competitive landscape, driven by technological advancements and an increasing prevalence of cardiovascular diseases. Major players such as Abbott (US), Boston Scientific (US), and Medtronic (US) are strategically positioned to leverage innovation and expand their market presence. Abbott (US) focuses on enhancing its product portfolio through continuous innovation, while Boston Scientific (US) emphasizes strategic partnerships to bolster its technological capabilities. Medtronic (US) is actively pursuing regional expansion and digital transformation initiatives, which collectively shape a competitive environment that is increasingly reliant on cutting-edge technology and strategic collaborations.Key business tactics within this market include localizing manufacturing and optimizing supply chains to enhance operational efficiency. The competitive structure appears moderately fragmented, with several key players exerting influence over market dynamics. This fragmentation allows for a diverse range of products and services, catering to varying customer needs while fostering competition among established and emerging companies.

In October Abbott (US) announced the launch of its latest coronary imaging system, which integrates advanced AI algorithms to improve diagnostic accuracy. This strategic move is likely to enhance Abbott's competitive edge by positioning it as a leader in innovative imaging solutions, thereby attracting healthcare providers seeking state-of-the-art technology.

In September Boston Scientific (US) entered into a partnership with a leading telehealth provider to enhance remote monitoring capabilities for patients undergoing coronary procedures. This collaboration underscores Boston Scientific's commitment to integrating digital health solutions, potentially improving patient outcomes and expanding its market reach in the growing telehealth sector.

In August Medtronic (US) completed the acquisition of a startup specializing in AI-driven analytics for cardiovascular imaging. This acquisition is expected to bolster Medtronic's technological capabilities, allowing it to offer more comprehensive solutions in the coronary angiography space, thus enhancing its competitive positioning.

As of November current trends in the coronary angiography-devices market include a pronounced shift towards digitalization, sustainability, and the integration of AI technologies. Strategic alliances are increasingly shaping the competitive landscape, enabling companies to pool resources and expertise. Looking ahead, competitive differentiation is likely to evolve from traditional price-based competition to a focus on innovation, advanced technology, and reliable supply chains, reflecting the industry's response to changing market demands.

Key Companies in the US Coronary Angiography Devices Market include

Industry Developments

Recent developments in the US Coronary Angiography Devices Market highlight significant growth and innovation. Abbott has launched new imaging technologies, enhancing procedural safety and effectiveness. Philips is advancing its integration of AI in cardiovascular imaging solutions.

This allows for improved patient outcomes. Medtronic is focusing on expanding its product portfolio. This is particularly in catheter-based intervention devices.

Boston Scientific is investing in clinical studies to validate efficacy of its latest offerings. In terms of mergers and acquisitions, Terumo acquired Merit Medical Systems in August 2023. This strengthened its presence in the US market.

Additionally, GE Healthcare announced its acquisition of a medical data analytics firm in May 2023. This aimed to bolster its technological capabilities in cardiac imaging. The market is witnessing an uptick in investment.

This is particularly in Research and Development initiatives. Leading companies like Johnson and Johnson and Stryker are increasing their allocation to drive innovation. Overall, the US Coronary Angiography Devices Market is evolving rapidly.

This is driven by technological advancements, strategic partnerships, and ongoing emphasis. This emphasis is on enhancing patient care through improved diagnostic and treatment solutions.

Future Outlook

US Coronary Angiography Devices Market Future Outlook

The Coronary Angiography Devices Market is projected to grow at 11.42% CAGR from 2025 to 2035, driven by technological advancements, increasing cardiovascular diseases, and rising healthcare expenditures.

New opportunities lie in:

  • Development of AI-driven imaging software for enhanced diagnostic accuracy.
  • Expansion of telehealth services for remote patient monitoring and consultations.
  • Introduction of portable angiography devices for outpatient settings.

By 2035, the market is expected to achieve substantial growth, reflecting evolving healthcare needs.

Market Segmentation

US Coronary Angiography Devices Market Type Outlook

  • Angiography Catheters
  • Contrast Media
  • Angiography Systems
  • Inflatable Balloons
  • Guidewires

US Coronary Angiography Devices Market End User Outlook

  • Hospitals
  • Ambulatory Surgical Centers
  • Diagnostic Imaging Centers
  • Specialty Clinics

US Coronary Angiography Devices Market Technology Outlook

  • Digital Angiography
  • Computed Tomography Angiography
  • Magnetic Resonance Angiography

US Coronary Angiography Devices Market Application Outlook

  • Coronary Angiography
  • Peripheral Angiography
  • Neuro Angiography
  • Interventional Angiography

Report Scope

MARKET SIZE 2024 2871.64(USD Million)
MARKET SIZE 2025 3199.59(USD Million)
MARKET SIZE 2035 9436.18(USD Million)
COMPOUND ANNUAL GROWTH RATE (CAGR) 11.42% (2025 - 2035)
REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR 2024
Market Forecast Period 2025 - 2035
Historical Data 2019 - 2024
Market Forecast Units USD Million
Key Companies Profiled Abbott (US), Boston Scientific (US), Medtronic (US), Siemens Healthineers (DE), Philips (NL), GE Healthcare (US), Cardinal Health (US), Terumo (JP), B. Braun (DE)
Segments Covered Type, Application, End User, Technology
Key Market Opportunities Integration of advanced imaging technologies enhances diagnostic accuracy in the coronary angiography-devices market.
Key Market Dynamics Technological advancements and regulatory changes drive innovation in the coronary angiography-devices market.
Countries Covered US

FAQs

What is the current market valuation of the US coronary angiography-devices market?

The market valuation was $2871.64 Million in 2024.

What is the projected market size for the US coronary angiography-devices market by 2035?

The projected market size is $9436.18 Million by 2035.

What is the expected CAGR for the US coronary angiography-devices market during the forecast period 2025 - 2035?

The expected CAGR is 11.42% during the forecast period 2025 - 2035.

Which segment had the highest valuation in the US coronary angiography-devices market in 2024?

The Angiography Systems segment had the highest valuation at $1200.0 Million in 2024.

What are the key players in the US coronary angiography-devices market?

Key players include Abbott, Boston Scientific, Medtronic, Siemens Healthineers, Philips, GE Healthcare, Cardinal Health, Terumo, and B. Braun.

How does the valuation of Contrast Media compare to Angiography Catheters in 2024?

In 2024, Contrast Media was valued at $600.0 Million, while Angiography Catheters were valued at $500.0 Million.

What is the valuation of the Peripheral Angiography segment in 2024?

The Peripheral Angiography segment was valued at $860.0 Million in 2024.

Which end user segment is expected to dominate the US coronary angiography-devices market by 2035?

Hospitals are expected to dominate, with a projected valuation of $4785.45 Million by 2035.

What technology segment is projected to have the highest growth in the US coronary angiography-devices market?

Digital Angiography is projected to have the highest growth, with a valuation of $3800.0 Million by 2035.

What is the valuation of the Guidewires segment in 2024?

The Guidewires segment was valued at $271.64 Million in 2024.

Author
Author
Author Profile
Rahul Gotadki LinkedIn
Research Manager
He holds an experience of about 9+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.
Leave a Comment
Download Free Sample

Kindly complete the form below to receive a free sample of this Report

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions